CRSP CRISPR Therapeutics AG
$54.11▲ +5.13%
Healthcare
Other
After hours
$53.87▼ -0.45%
Oct 28, 7:57 PM ET
Volume 1.13M
Avg Volume (10D) 1.41M
Key Metrics & Fundamentals
Market Cap
$5.23B
P/E Ratio
–
Div Yield
0.00%
52W Range
44.12 - 65.98
% vs 50 MA
-0.60%
% vs 200 MA
2.25%
RSI-14
55.6
MACD Histogram
+0.2700
Beta (1Y vs SPY)
1.89
Free Cash Flow
-$86.62M
Gross Rev
$10.00M
Gross Profit
-$30.27M
EBITDA
-$112.99M
COGS
$40.27M
Operating Exp
$87.00M
Operating Income
-$117.27M
EBIT
-$117.27M
Pretax Income
-$90.19M
Net Income
-$91.15M
EPS (Diluted)
-0.94
Price & Volume History
Loading chart…
Recent News
Vertex Gears Up to Report Q3 Earnings: Is a Beat in the Cards?
Zacks · Oct 27, 2026 10:15 AM ET
Learn Why The Bull Case For CRISPR Therapeutics Stock Could Change Following CFO Change
Simply Wall St. · Oct 25, 2026 5:10 AM ET
CRISPR Therapeutics (CRSP) Promotes Andrew Silver To CFO As Raju Prasad Resigns
Simply Wall St. · Oct 25, 2026 4:12 AM ET
Forget Casgevy: CRISPR Therapeutics' Heart-Disease Data Could Matter More
Motley Fool · Oct 24, 2026 6:20 PM ET
CRISPR Therapeutics AG (CRSP) Dips More Than Broader Market: What You Should Know
Zacks · Oct 23, 2026 4:50 PM ET
Investors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
Zacks · Oct 23, 2026 8:00 AM ET
The Outlook of CRISPR Therapeutics Stock Does Not Look Strong After Its CFO Resigns
Barchart · Oct 23, 2026 7:14 AM ET
CRISPR Therapeutics AG (CRSP) Stock Moves -1.21%: What You Should Know
Zacks · Oct 22, 2026 5:00 PM ET
Brokers Suggest Investing in CRISPR Therapeutics (CRSP): Read This Before Placing a Bet
Zacks · Oct 21, 2026 8:30 AM ET
CRISPR Therapeutics Names A.J. Silver as New Chief Financial Officer
MT Newswires · Oct 19, 2026 4:33 PM ET
Financial Overview - Income Statement
Quarterly
Jun 2026
See CRSP's money flow as a full page
Social Sentiment
Loading Reddit posts…
AI Analysis
Click Generate Analysis for an AI-powered summary, bull & bear case, and recent performance review.
Not financial advice.
All data, scores, charts, and analysis on this site are provided for informational and educational
purposes only and do not constitute financial, investment, legal, or tax advice.
Past performance is not indicative of future results.
See our Legal Notice for full details.